跳至主要内容
临床试验/CTRI/2025/04/084715
CTRI/2025/04/084715尚未招募不适用

Utility of molecular over traditional diagnostic method in diagnosis and management of ventilator associated pneumonia caused by Gram negative bacteria in intensive care unit

Dr Avinash Agrawal1 个研究点 分布在 1 个国家目标入组 184 人开始时间: 2025年4月24日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
184
试验地点
1
主要终点
To study the outcome 28 days mortality of early molecular identification of Gram negative organisms causing VAP and identification of common carbapenem resistant genes KPC IMP VIM NDM or OXA 48 compared with traditional culture methods

研究概览

简要总结

The study aims at evaluating the diagnostic performance of molecular based PCR compared to standard microbiological culture test

and the potential impact of its results on early modification of antimicrobial therapy along with clinical outcomes in  ICU patients with clinically defined VAP.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • patients having clinically defined VAP according to CDC Age more than or equal to 18 years.

排除标准

  • Patients with evidence of chest infection prior to intubation or within 48 hours of mechanical ventilation Patients with severely immunocompromised state such as Acquired Immune Deficiency Syndrome organ transplant patients terminal stage of malignancy Patients whose sample could not be obtained Patients who are not willing to participate or give consent.

结局指标

主要结局

To study the outcome 28 days mortality of early molecular identification of Gram negative organisms causing VAP and identification of common carbapenem resistant genes KPC IMP VIM NDM or OXA 48 compared with traditional culture methods

时间窗: At baseline 4 weeks and 90 days

次要结局

  • To compare the change in targeted antibiotic therapy selection according to molecular method and culture method(2 days)
  • To compare the change in Clinical Pulmonary Infection Score on third day of management on the basis of molecular method and culture method(3 days)
  • To compare the effect of diagnosis and management of VAP by both the methods on 90 days mortality(90 days)

研究者

发起方
Dr Avinash Agrawal
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Krishna Priya Agrawal

King Georges Medical University Lucknow

研究点 (1)

Loading locations...

相似试验